BioNTech SE (22UA) — Free Cash Flow Generation Index
BioNTech SE (22UA) has a Free Cash Flow Generation Index of 0.80x as of December 2025. Free cash flow of €247.40 Million represents 1% of operating cash flow (€309.50 Million). See working capital position of BioNTech SE to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BioNTech SE Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for BioNTech SE across 5 annual periods. Explore 22UA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for BioNTech SE (2021–2025)
Year-by-year Free Cash Flow Generation Index for BioNTech SE. For the full company profile including market capitalisation, see 22UA market cap overview.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.64x | €-293.00 Million | €456.00 Million | €749.00 Million | ▲ +45.4% |
| 2024 | -1.18x | €-244.60 Million | €207.70 Million | €452.30 Million | ▼ -235.6% |
| 2023 | 0.87x | €4.67 Billion | €5.37 Billion | €705.50 Million | ▼ -10.7% |
| 2022 | 0.97x | €13.21 Billion | €13.58 Billion | €363.30 Million | ▲ +17.7% |
| 2021 | 0.83x | €735.70 Million | €889.70 Million | €127.50 Million | — |